Literature DB >> 14757701

Nicotine attenuates beta-amyloid peptide-induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures.

Qiang Liu1, Baolu Zhao.   

Abstract

1. Recent studies indicate that neuronal loss in Alzheimer's disease (AD) is accompanied by the deposition of beta-amyloid protein (A beta) in senile plaques. Nicotine as a major component of cigarette smoke has been suggested to have a protective effect for neurons against A beta neurotoxicity. 2. Our present study demonstrates that nicotine protected cultured hippocampal neurons against the A beta-induced apoptosis. Nicotine effectively inhibits apoptosis in hippocampal cultures caused by A beta(25-35) or A beta(1-40) treatment and increase of caspase activity induced by A beta(25-35) or A beta(1-40). 3. Measurements of cellular oxidation and intracellular free Ca(2+) showed that nicotine suppressed A beta-induced accumulation of free radical and increase of intracellular free Ca(2+). 4. Cholinergic antagonist mecamylamine inhibited nicotine-induced protection against A beta-induced caspase-3 activation and ROS accumulation. 5. The data show that the protection of nicotine is partly via nicotinic receptors. Our results suggest that nicotine may be beneficial in retarding the neurodegenerative diseases such as AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14757701      PMCID: PMC1574236          DOI: 10.1038/sj.bjp.0705653

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  63 in total

1.  Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants.

Authors:  C J Pike; N Ramezan-Arab; C W Cotman
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

Review 2.  The cause of neuronal degeneration in Alzheimer's disease.

Authors:  J C Vickers; T C Dickson; P A Adlard; H L Saunders; C E King; G McCormack
Journal:  Prog Neurobiol       Date:  2000-02       Impact factor: 11.685

3.  Nicotine and amyloid formation.

Authors:  H Zeng; Y Zhang; L Peng; H Shao; N K Menon; J Yang; A R Salomon; R P Freidland; M G Zagorski
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

Review 4.  Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.

Authors:  S Shimohama; T Kihara
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

5.  The alpha7 nicotinic acetylcholine receptor subtype mediates nicotine protection against NMDA excitotoxicity in primary hippocampal cultures through a Ca(2+) dependent mechanism.

Authors:  F A Dajas-Bailador; P A Lima; S Wonnacott
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

6.  Melatonin prevents beta-amyloid-induced lipid peroxidation.

Authors:  W M Daniels; S J van Rensburg; J M van Zyl; J J Taljaard
Journal:  J Pineal Res       Date:  1998-03       Impact factor: 13.007

7.  Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons.

Authors:  R Garrido; A Malecki; B Hennig; M Toborek
Journal:  Brain Res       Date:  2000-04-07       Impact factor: 3.252

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  Vitamin E protects nerve cells from amyloid beta protein toxicity.

Authors:  C Behl; J Davis; G M Cole; D Schubert
Journal:  Biochem Biophys Res Commun       Date:  1992-07-31       Impact factor: 3.575

10.  The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation.

Authors:  J R Brorson; V P Bindokas; T Iwama; C J Marcuccilli; J C Chisholm; R J Miller
Journal:  J Neurobiol       Date:  1995-03
View more
  37 in total

Review 1.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

Review 2.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects.

Authors:  Young-Hoon Sung; Deborah A Yurgelun-Todd; Douglas G Kondo; Xian-Feng Shi; Kelly J Lundberg; Tracy L Hellem; Rebekah S Huber; Erin C McGlade; Eun-Kee Jeong; Perry F Renshaw
Journal:  Am J Drug Alcohol Abuse       Date:  2015-04-14       Impact factor: 3.829

4.  Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.

Authors:  Robert L Copeland; Yaminah A Leggett; Yasmine M Kanaan; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

5.  Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer's disease: underlying mechanisms.

Authors:  Tourandokht Baluchnejadmojarad; Seyed-Mahdi Mohamadi-Zarch; Mehrdad Roghani
Journal:  Metab Brain Dis       Date:  2019-08-17       Impact factor: 3.584

6.  Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.

Authors:  Carlana Ramlochansingh; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-01-08       Impact factor: 3.911

7.  Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.

Authors:  A Khanna; M Guo; M Mehra; W Royal
Journal:  J Neuroimmunol       Date:  2012-09-30       Impact factor: 3.478

8.  Nicotine reduces the cytotoxic effect of glycated proteins on microglial cells.

Authors:  Mohammad R Khazaei; Mostafa Bakhti; Mehran Habibi-Rezaei
Journal:  Neurochem Res       Date:  2009-11-28       Impact factor: 3.996

9.  Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and D-amphetamine-treated rats.

Authors:  A Toledano; M I Alvarez; I Caballero; P Carmona; E De Miguel
Journal:  J Neural Transm (Vienna)       Date:  2008-03-20       Impact factor: 3.575

10.  Nicotine promotes survival of cells expressing amyloid precursor protein and presenilin: implication for Alzheimer's disease.

Authors:  Dwayne Brown; Carlana Ramlochansingh; Kebreten F Manaye; Yousef Tizabi
Journal:  Neurosci Lett       Date:  2013-01-08       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.